Clinical Utility for Ion Endoluminal System
Phase NA Unknown
365 enrolled
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
Unknown
148 enrolled
ILST
Phase NA Unknown
2,000 enrolled
Holo-lungs
Unknown
50 enrolled
3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-blinded Randomized Controlled Trial
Phase NA Unknown
200 enrolled
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC
Phase 2 Unknown
146 enrolled
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Unknown
133 enrolled
Breath Analysis by Ion Mobility Spectrometry
Unknown
1,000 enrolled
To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery
Phase NA Unknown
15 enrolled
The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)
Phase 3 Unknown
100 enrolled
A Clinical Study of LUNG-CT CAD Decision Support
Phase NA Unknown
8 enrolled
SOME-RIETE
Phase 4 Unknown
650 enrolled
Clinical Evaluation of ASP Health's Automated ROSE System for Bronchoscopic Applications
Unknown
100 enrolled
VATS
Phase 4 Unknown
40 enrolled
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Unknown
279 enrolled
COVID19REHAB
Phase NA Unknown
40 enrolled
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma
Phase 2 Unknown
27 enrolled
EPIC
Phase 3 Unknown
567 enrolled
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Phase 2 Unknown
20 enrolled
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Phase 1/2 Unknown
20 enrolled
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Phase 2 Unknown
144 enrolled
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Phase 3 Unknown
417 enrolled
VOCs
Unknown
230 enrolled
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Unknown
200 enrolled
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
Unknown
1,000 enrolled
Advance Care Planning: A Way to Improve End-of-life Care Life Care
Phase NA Unknown
360 enrolled